Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

CD-437, a novel retinoid compound targeted to the treatment of leukemia

Feb. 18, 1999

Specific inhibitors of MEK for cancer and other proliferative disorders

Feb. 18, 1999

Zarix in-licenses oncology drug from Agouron

Feb. 18, 1999

Initial findings reported for CollaGenex's anticancer compound

Feb. 17, 1999

Wistar Institute discovers mechanism of action of farnesyltransferase inhibitors

Feb. 17, 1999

First pivotal trial results reported for marimastat; BB to assess implications for development

Feb. 16, 1999

Available for licensing from NIH: BOG gene and protein product for Rx, Dx use

Feb. 15, 1999

U. of Arizona prepares novel cyanoaziridine-based antitumor agents

Feb. 15, 1999

ProScript initiates second phase I trial for PS-341

Feb. 15, 1999

Aronex initiates phase I/II trial of Atragen + interferon alfa in renal cell carcinoma

Feb. 15, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
ADEL wins $1.04B Sanofi deal for tau-targeting Alzheimer’s drug
BioWorld
ADEL Inc. closed a year-end licensing deal worth up to $1.04 billion with Sanofi SA for ADEL-Y01, a specific tau-targeting Alzheimer’s disease drug candidate in a...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...